AIM
Advantage Investment Management’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $0 | Hold |
114
| – | – | ﹤0.01% | 916 |
|
|
2019
Q2 | $0 | Hold |
114
| – | – | ﹤0.01% | 930 |
|
|
2019
Q1 | $1K | Sell |
114
-1,611
| -93% | -$14.1K | ﹤0.01% | 887 |
|
|
2018
Q4 | $0 | Hold |
1,725
| – | – | ﹤0.01% | 993 |
|
|
2018
Q3 | $1K | Hold |
1,725
| – | – | ﹤0.01% | 965 |
|
|
2018
Q2 | $1K | Hold |
1,725
| – | – | ﹤0.01% | 898 |
|
|
2018
Q1 | $4K | Hold |
1,725
| – | – | ﹤0.01% | 827 |
|
|
2017
Q4 | $5K | Buy |
1,725
+1,225
| +245% | +$3.55K | ﹤0.01% | 813 |
|
|
2017
Q3 | $1K | Hold |
500
| – | – | ﹤0.01% | 975 |
|
|
2017
Q2 | $1K | Hold |
500
| – | – | ﹤0.01% | 1008 |
|
|
2017
Q1 | $2K | Hold |
500
| – | – | ﹤0.01% | 892 |
|
|
2016
Q4 | $2K | Sell |
500
-6,920
| -93% | -$27.7K | ﹤0.01% | 840 |
|
|
2016
Q3 | $30K | Buy |
7,420
+660
| +10% | +$2.67K | 0.01% | 433 |
|
|
2016
Q2 | $30K | Buy |
6,760
+752
| +13% | +$3.34K | 0.01% | 420 |
|
|
2016
Q1 | $23K | Buy |
6,008
+264
| +5% | +$1.01K | 0.01% | 437 |
|
|
2015
Q4 | $90K | Buy |
5,744
+267
| +5% | +$4.18K | 0.05% | 247 |
|
|
2015
Q3 | $58K | Buy |
5,477
+5
| +0.1% | +$53 | 0.03% | 291 |
|
|
2015
Q2 | $138K | Sell |
5,472
-224
| -4% | -$5.65K | 0.07% | 186 |
|
|
2015
Q1 | $159K | Buy |
5,696
+758
| +15% | +$21.2K | 0.09% | 165 |
|
|
2014
Q4 | $90K | Buy |
+4,938
| New | +$90K | 0.07% | 227 |
|